Reference health
Management of Early Treated Adolescents and Young Adults with Phenylketonuria: Development of International Consensus Recommendations Using a Modified Delphi Approach
79/79 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
25 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 79 checked references that resolve
resolves10.3389/fpsyt.2019.00561
Psychiatric and Cognitive Aspects of Phenylketonuria: The Limitations of Diet and Promise of New Treatments
resolves10.1038/gim.2013.157
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
resolves10.1038/s41436-018-0403-z
Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria
resolves10.1016/j.ymgme.2019.07.018
Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria
resolves10.1016/j.ymgme.2017.03.002
Neuropsychiatric comorbidities in adults with phenylketonuria: A retrospective cohort study
resolves10.1186/s13023-019-1153-y
Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data
resolves10.1016/j.ymgme.2017.01.001
Adherence to clinic recommendations among patients with phenylketonuria in the United States
resolves10.1016/j.ymgme.2010.05.017
Suboptimal outcomes in patients with PKU treated early with diet alone: Revisiting the evidence
resolves10.3390/nu13093118
Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations
resolves10.1016/j.ejmg.2019.103818
Adult patient perspectives on phenylketonuria care: Highlighting the need for dedicated adult management and services
resolves10.1186/s13023-021-02086-8
Italian national consensus statement on management and pharmacological treatment of phenylketonuria
resolves10.1016/j.gene.2012.05.007
Depressive symptoms in adolescents with early and continuously treated phenylketonuria: Associations with phenylalanine and tyrosine levels
resolves10.1080/87565640903325725
A Preliminary Investigation of the Role of the Phenylalynine:Tyrosine Ratio in Children With Early and Continuously Treated Phenylketonuria: Toward Identification of “Safe” Levels
resolves10.1007/s10545-012-9548-0
Chronic kidney disease in adolescent and adult patients with phenylketonuria
resolves10.1097/MPG.0b013e3182093b32
Impact of Metabolic Control on Bone Quality in Phenylketonuria and Mild Hyperphenylalaninemia
resolves10.3390/nu13103443
Is the Phenylalanine-Restricted Diet a Risk Factor for Overweight or Obesity in Patients with Phenylketonuria (PKU)? A Systematic Review and Meta-Analysis
resolves10.1016/j.ymgme.2015.04.003
Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: A longitudinal study
resolves10.1037/neu0000336
The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
resolves10.1023/A:1005664231017
Behavioural and emotional problems in early‐treated adolescents with phenylketonuria in comparison with diabetic patients and healthy controls
resolves10.1007/s10964-018-0976-5
Identifying Critical Points of Trajectories of Depressive Symptoms from Childhood to Young Adulthood
resolves10.1007/8904_2016_579
Brain White Matter Integrity Mediates the Relationship Between Phenylalanine Control and Executive Abilities in Children with Phenylketonuria
resolves10.1080/87565641.2016.1243109
Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria
resolves10.1016/j.nicl.2019.101916
White and gray matter brain development in children and young adults with phenylketonuria
resolves10.1007/s10545-016-9918-0
Social‐cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU‐COBESO study
resolves10.1590/S1678-77572009000700012
Communicative and psycholinguistic abilities in children with phenylketonuria and congenital hypothyroidism
resolves10.1016/j.ymgme.2009.10.009
Beyond executive function: Non-executive cognitive abilities in individuals with PKU☆
resolves10.1017/S0012162205000861
Cognitive functions in classic phenylketonuria and mild hyperphenyl-alaninaemia: experience in a paediatric population
resolves10.1037/neu0000758
Motor control and learning in individuals with early-treated phenylketonuria.
resolves10.1023/A:1005587915468
Regression of neuropsychological deficits in early‐treated phenylketonurics during adolescence
resolves10.1186/s13023-018-0893-4
A systematic review of cognitive functioning in early treated adults with phenylketonuria
resolves10.1007/s10545-012-9564-0
Estimating the probability of IQ impairment from blood phenylalanine for phenylketonuria patients: a hierarchical meta‐analysis
resolves10.1007/s10545-011-9329-1
Correlation of age‐specific phenylalanine levels with intellectual outcome in patients with phenylketonuria
resolves10.1037/neu0000337
Cognitive outcomes in early-treated adults with phenylketonuria (PKU): A comprehensive picture across domains.
resolves10.1136/jmedgenet-2019-106278
Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalised therapy: the challenge for the future guidelines
resolves10.1001/jamapsychiatry.2019.0943
Burden of Environmental Adversity Associated With Psychopathology, Maturation, and Brain Behavior Parameters in Youths
resolves10.1016/j.semcdb.2017.09.040
The impact of adolescent stress experiences on neurobiological development
resolves10.1186/s12888-019-2349-3
Anxiety at age 15 predicts psychiatric diagnoses and suicidal ideation in late adolescence and young adulthood: results from two longitudinal studies
resolves10.1001/archgenpsychiatry.2010.127
Very Early Predictors of Adolescent Depression and Suicide Attempts in Children With Attention-Deficit/Hyperactivity Disorder
resolves10.1016/j.jaac.2018.05.016
Interaction Between Parenting Styles and Adrenarcheal Timing Associated With Affective Brain Function in Late Childhood
resolves10.1016/j.dcn.2013.10.006
Positive parenting predicts the development of adolescent brain structure: A longitudinal study
resolves10.1001/jamapsychiatry.2017.1558
Role of Positive Parenting in the Association Between Neighborhood Social Disadvantage and Brain Development Across Adolescence
resolves10.1097/00004703-200506000-00004
Situational Analysis of Dietary Challenges of the Treatment Regimen for Children and Adolescents with Phenylketonuria and Their Primary Caregivers
resolves10.1542/peds.99.3.345
Psychiatric Disorders in Adult Patients With Early-treated Phenylketonuria
resolves10.1089/acm.2016.0334
The Effects of Yoga on Positive Mental Health Among Healthy Adults: A Systematic Review and Meta-Analysis
resolves10.1037/neu0000625
Executive function in phenylketonuria (PKU): Insights from the Behavior Rating Inventory of Executive Function (BRIEF) and a large sample of individuals with PKU.
resolves10.1016/j.ymgme.2014.12.302
Is BRIEF a useful instrument in day to day care of patients with phenylketonuria?
resolves10.1177/2326409816669374
Assessing the Content Validity of the Investigator-Rated ADHD Rating Scale Version IV Instrument Inattention Subscale for Use in Adults With Phenylketonuria
resolves10.1007/s11065-007-9021-2
Meta-Analysis of Neuropsychological Symptoms of Adolescents and Adults with PKU
resolves10.1080/87565640701375963
Are Neuropsychological Impairments in Children with Early-Treated Phenylketonuria (PKU) Related to White Matter Abnormalities or Elevated Phenylalanine Levels?
resolves10.1080/00221325.2012.717122
Disentangling Fine Motor Skills’ Relations to Academic Achievement: The Relative Contributions of Visual-Spatial Integration and Visual-Motor Coordination
resolves10.1016/S0022-3476(95)70303-9
Magnetic resonance imaging in phenylketonuria: Reversal of cerebral white matter change
resolves10.1016/j.ymgme.2013.03.020
White matter integrity and executive abilities in individuals with phenylketonuria
resolves10.1016/j.ymgme.2013.07.010
White matter integrity and executive abilities following treatment with tetrahydrobiopterin (BH4) in individuals with phenylketonuria
resolves10.1016/j.ymgme.2014.11.011
A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria
resolves10.1016/j.ymgme.2018.03.006
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)
resolves10.1186/s13023-020-01668-2
The effect of improved dietary control on cognitive and psychiatric functioning in adults with phenylketonuria: the ReDAPT study
resolves10.1016/j.cell.2021.01.034
Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
resolves10.1212/WNL.0000000000011088
Phenylalanine Effects on Brain Function in Adult Phenylketonuria
resolves10.24953/turkjped.2018.06.001
Cognitive and behavioral impairment in mild hyperphenylalaninemia
resolves10.1016/j.jpeds.2013.12.015
Neurocognitive Evidence for Revision of Treatment Targets and Guidelines for Phenylketonuria
resolves10.1186/s13023-019-1225-z
Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels
resolves10.1080/13803395.2019.1696753
Emotional health in early-treated adults with phenylketonuria (PKU): Relationship with cognitive abilities and blood phenylalanine
resolves10.1016/j.ymgme.2018.03.003
Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial
resolves10.1016/j.yhbeh.2013.02.019
Puberty as a critical risk period for eating disorders: A review of human and animal studies
resolves10.1016/S0002-8223(00)00232-7
Impact of a Camp Experience on Phenylalanine Levels, Knowledge, Attitudes, and Health Beliefs Relevant to Nutrition Management of Phenylketonuria in Adolescent Girls
resolves10.2196/jmir.4883
The Effectiveness of Self-Management Mobile Phone and Tablet Apps in Long-term Condition Management: A Systematic Review
resolves10.3390/nu13030799
Implementing a Transition Program from Paediatric to Adult Services in Phenylketonuria: Results after Two Years of Follow-Up with an Adult Team
resolves10.1159/000342256
Adherence Issues in Inherited Metabolic Disorders Treated by Low Natural Protein Diets
resolves10.1016/j.acap.2014.03.008
The Transition Readiness Assessment Questionnaire (TRAQ): Its Factor Structure, Reliability, and Validity
The 25 references without a DOI — listed, not checked
no DOI — not checkedThe complete European guidelines on phenylketonuria: diagnosis and treatment
no DOI — not checkedref5
no DOI — not checkedref6
no DOI — not checkedPrevalence of comorbid conditions among adult patients diagnosed with phenylketonuria
no DOI — not checkedref18
no DOI — not checkedLongterm cognitive and psychosocial outcomes in adults with phenylketonuria
no DOI — not checkedPsychological wellbeing in parents of children with phenylketonuria and association with treatment adherence
no DOI — not checkedref60
no DOI — not checkedref62
no DOI — not checkedref63
no DOI — not checkedref64
no DOI — not checkedref65
no DOI — not checkedref66
no DOI — not checkedA noninterventional observational study to identify and validate clinical outcome assessments for adults with phenylketonuria for use in clinical trials
no DOI — not checkedref78
no DOI — not checkedThe role of sport involvement in reducing depressive symptoms via changes to hippocampal structure: next steps for research in developing samples
no DOI — not checkedDevelopment of a practical dietitian road map for the nutritional management of phenylketonuria (PKU) patients on pegvaliase
no DOI — not checkedA survey of eating attitudes and behaviors in adolescents and adults with phenylalanine hydroxylase deficiency
no DOI — not checkedPKU and COVID19: How the pandemic changed metabolic control
no DOI — not checkedThe impact of telemedicine for monitoring and treatment of phenylketonuria patients on metabolic outcome during coronavirus disease-19 outbreak
no DOI — not checkedHealth technologies for monitoring and managing diabetes: a systematic review
no DOI — not checkedAmerican Academy Of P, American Academy Of Family P, American College Of P. Supporting the health care transition from adolescence to adulthood in the medical home
no DOI — not checkedref101
no DOI — not checkedTen years of specialized adult care for phenylketonuria -a single-centre experience
no DOI — not checkedChallenges in Transition From Childhood to Adulthood Care in Rare Metabolic Diseases: Results From the First Multi-Center European Survey
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.4094089"><img src="https://citestamp.com/citestamped/10.2139/ssrn.4094089/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.4094089)